Skip to main content
PMC home page
AAPS PharmSciTech logoLink to AAPS PharmSciTech
. 2014 Mar 30;7(4):E133–E140. doi: 10.1208/pt0704103

Chargeability measurements of selected pharmaceutical dry powders to assess their electrostatic charge control capabilities

Juan-Carlos Ramirez-Dorronsoro 1,✉, Robert B Jacko 1,✉, Dane O Kildsig 2
PMCID: PMC2750340  PMID: 17285749

Abstract

The purpose of this study was to develop an instrument (the Purdue instrument) and the corresponding methodologies to measure the electrostatic charge development (chargeability) of dry powders when they are in dynamic contact with stainless steel surfaces. The system used an inductive noncontact sensor located inside an aluminum Faraday cage and was optimized to measure the charging capabilities of a fixed volume of powder (0.5 cc). The chargeability of 5,5-diphenyl-hydantoin, calcium sulfate dihydrate, cimetidine, 3 grades of colloidal silicon dioxide, magnesium stearate, 4 grades of microcrystalline cellulose, salicylic acid, sodium carbonate, sodium salicylate, spray-dried lactose, and sulfin-pyrazone were tested at 4 linear velocities, and the particle size distribution effect was assessed for 3 different grades of colloidal silicon dioxide and 4 different grades of micro-crystalline cellulose. The chargeability values exhibited a linear relationship for the range of velocities studied, with colloidal silicon dioxide exhibiting the maximum negative chargeability and with spray-dried lactose being the only compound to exhibit positive chargeability. The instrument sensitivity was improved by a factor of 2 over the first generation version, and the electrostatic charge measurements were reproducible with relative standard deviations ranging from nondetectable to 33.7% (minimum of 3 replicates). These results demonstrate the feasibility of using the Purdue instrument to measure the electrostatic charge control capabilities of pharmaceutical dry powders with a reasonable level of precision.

Keywords: Powders, charge control, electrostatic, chargeability, triboelectricity, excipients

Full Text

The Full Text of this article is available as a PDF (223.0 KB).

Footnotes

Deceased

References

  • 1.Bailey AG, Hashish AH, Williams TJ. Drug delivery by inhalation of charged particles. J Electrostatics. 1998;44:3–10. doi: 10.1016/S0304-3886(98)00017-5. [DOI] [Google Scholar]
  • 2.Lucas P, Anderson K, Potter UJ, Staniforth JN. Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm Res. 1999;16:1643–1647. doi: 10.1023/A:1011981326827. [DOI] [PubMed] [Google Scholar]
  • 3.Zeng XM, Martin GP, Marriot C. Particulate Interactions in Dry Powder Formulations for Inhalations. New York, NY: Taylor and Francis; 2001. [Google Scholar]
  • 4.Staniforth JN, Rees JE. Electrostatic charge interactions in ordered powder mixes. J Pharm Pharmacol. 1982;34:69–76. doi: 10.1111/j.2042-7158.1982.tb04188.x. [DOI] [PubMed] [Google Scholar]
  • 5.Carter PA, Rowley G, Fletcher EJ, Hill EA. An experimental investigation of triboelectrification in cohesive and non-cohesive pharmaceutical powders. Drug Dev Ind Pharm. 1992;18:1505–1526. doi: 10.3109/03639049209040855. [DOI] [Google Scholar]
  • 6.Rogers B. Difficulties associated with compounding metered-dose inhalers and dry powder inhalers [Powerpoint presentation]. U.S. FDA, Center for Drug Evaluation and Research, Office of New Drug Chemistry, Pharmacy Compounding Advisory Committee. Available at: http://www.fda.gov/ohrms/dockets/ac/00/slides/3634s1_07_rogers.ppt. Accessed: July 19, 2003.
  • 7.Wade EA, Weller PJ, editors. Handbook of Pharmaceutical Excipients. 2nd ed. Washington, DC: American Pharmaceutical Association; 1994. [Google Scholar]
  • 8.Cabot Corporation . Cab-O-Sil untreated fumed silica properties and functions [catalog no. TD-100] Tuscola, IL: Cabot Corporation; 1993. [Google Scholar]
  • 9.Bavin PMG, Post A, Zarembo JE. Cimetidine. In: Florey K, editor. Analytical Profiles of Drug Substances. Orlando, FL: Academic Press; 1984. [Google Scholar]
  • 10.Kibbe AH, editor. Handbook of Pharmaceutical Excipients. 3rd ed. Washington, DC: Pharmaceutical Press; 2000. [Google Scholar]
  • 11.Pujara CP. Determination of Factors That Affect the Generation of Airborne Particles From Bulk Pharmaceutical Powders. West Lafayette, IN: Industrial and Physical Pharmacy, Purdue University; 1997. [Google Scholar]
  • 12.Abounassif MA, Mian MS, Mian AA. Salicylic acid. In: Brittain H, editor. Analytical Profiles of Drug Substances. Orlando, FL: Academic Press; 1994. [Google Scholar]
  • 13.Sodium Salicylate MSDS. Available at: www.skylighter.com/msds/ sodium_salicylate.txt. Accessed: July 19, 2003.
  • 14.Monograph 8541. Sodium Carbonate. In: Budavary S, ed. The Merck Index. 11th ed. Whitehouse Station, NJ: Merck & Co; 1989.
  • 15.Ghosh R. Pharmaceutical Powder Chargeability and Dustiness Characterization. West Lafayette, IN: Purdue University; 1997. [Google Scholar]
  • 16.Gajewski JB, Szaynok A. Charge measurement of dust particles in motion. J Electrostatics. 1981;10:229–234. doi: 10.1016/0304-3886(81)90047-4. [DOI] [Google Scholar]
  • 17.USI . US Pharmacopeia National Formulary. Rockville, MD: USP; 1999. [Google Scholar]
  • 18.Eilbeck J, Rowley G, Carter PA, Fletcher EJ. Effect of contamination of pharmaceutical equipment on powder triboelectrification. Int J Pharm. 2000;195:7–11. doi: 10.1016/S0378-5173(99)00351-8. [DOI] [PubMed] [Google Scholar]
  • 19.Murtomaa M, Harjunen P, Mellin V, Lehto V-P, Laine E. Effect of amorphicity on the triboelectrification of lactose powder. J Electrostatics. 2002;56:103–110. doi: 10.1016/S0304-3886(02)00066-9. [DOI] [Google Scholar]
  • 20.Reis GE, Bierly JN, Schwartz JB. Characterizing electrostatic charge in pharmaceutical powders. Am J Pharm. 1984;156:100–105. [Google Scholar]
  • 21.Watano S, Suzuki T, Taira T, Miyanami K. Continuous monitoring and mechanism of electrostatic charge of powder in fluidized bed process. Chem Pharm Bull (Tokyo) 1998;46:1438–1443. doi: 10.1248/cpb.46.1438. [DOI] [Google Scholar]
  • 22.Murtomaa M, Rasanen E, Rantanen J, et al. Electrostatic measurements on a miniaturized fluidized bed. J Electrostatics. 2003;57:91–106. doi: 10.1016/S0304-3886(02)00121-3. [DOI] [Google Scholar]
  • 23.Swaminathan V, Kildsig DO. Effect of particle morphology on the physical stability of pharmaceutical powder mixtures: effect of surface roughness of the carrier on the stability of ordered mixtures. Drug Dev Ind Pharm. 2000;26:365–373. doi: 10.1081/DDC-100101242. [DOI] [PubMed] [Google Scholar]
  • 24.Bennett FS, Carter PA, Rowley G, Dandiker Y. Modification of electrostatic charge on inhaled carrier lactose particles by addition of fine particles. Drug Dev Ind Pharm. 1999;25:99–103. doi: 10.1081/DDC-100102148. [DOI] [PubMed] [Google Scholar]
  • 25.Zhao H, Castle GSP, Inculet II. The measurement of bipolar charge in polydisperse powders using a vertical array of Faraday pail sensors. J Electrostatics. 2002;55:261–278. doi: 10.1016/S0304-3886(01)00209-1. [DOI] [Google Scholar]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists

RESOURCES